BioSpace News Archive

Aerie Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2020 and provided a general business update, including the impact of the COVID-19 pandemic on company operations.

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced topline results from its INTREPID Phase 2 study of EDP-305, a Farnesoid X receptor, in subjects with primary biliary cholangitis.

Blue Cross and Blue Shield coverage decisions add nearly 10 million covered lives for Eversense CGM

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported financial results for the first quarter ended April 3, 2020.

Increased total revenue by 16% year-over-year to $80 million, driven primarily by U.S. LINZESS collaboration revenue of $71 million

PPD, Inc., a leading global contract research organization, reported its financial results for the first quarter ended March 31, 2020.

Atara Biotherapeutics, Inc., a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, reported financial results for the first quarter ended March 31, 2020 and recent business highlights.

Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, announced financial results for the three months ended March 31, 2020.

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Tuesday, May 12, 2020, 5:00 p.m. ET

Amedisys, Inc. reported its financial results for the three-month period ended March 31, 2020.